Literature DB >> 22634635

Deciphering biased-agonism complexity reveals a new active AT1 receptor entity.

Aude Saulière1, Morgane Bellot, Hervé Paris, Colette Denis, Frédéric Finana, Jonas T Hansen, Marie-Françoise Altié, Marie-Hélène Seguelas, Atul Pathak, Jakob L Hansen, Jean-Michel Sénard, Céline Galés.   

Abstract

Functional selectivity of G protein-coupled receptor (GPCR) ligands toward different downstream signals has recently emerged as a general hallmark of this receptor class. However, pleiotropic and crosstalk signaling of GPCRs makes functional selectivity difficult to decode. To look from the initial active receptor point of view, we developed new, highly sensitive and direct bioluminescence resonance energy transfer-based G protein activation probes specific for all G protein isoforms, and we used them to evaluate the G protein-coupling activity of [(1)Sar(4)Ile(8)Ile]-angiotensin II (SII), previously described as an angiotensin II type 1 (AT(1)) receptor-biased agonist that is G protein independent but β-arrestin selective. By multiplexing assays sensing sequential signaling events, from receptor conformations to downstream signaling, we decoded SII as an agonist stabilizing a G protein-dependent AT(1A) receptor signaling module different from that of the physiological agonist angiotensin II, both in recombinant and primary cells. Thus, a biased agonist does not necessarily select effects from the physiological agonist but may instead stabilize and create a new distinct active pharmacological receptor entity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634635     DOI: 10.1038/nchembio.961

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  49 in total

Review 1.  The role of conformational ensembles of seven transmembrane receptors in functional selectivity.

Authors:  Nagarajan Vaidehi; Terry Kenakin
Journal:  Curr Opin Pharmacol       Date:  2010-12       Impact factor: 5.547

2.  Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking.

Authors:  Denis J Dupré; Mélanie Robitaille; Nathalie Ethier; Louis R Villeneuve; Aida M Mamarbachi; Terence E Hébert
Journal:  J Biol Chem       Date:  2006-09-07       Impact factor: 5.157

3.  The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferation.

Authors:  Jakob Lerche Hansen; Mark Aplin; Jonas Tind Hansen; Gitte Lund Christensen; Marie Mi Bonde; Mikael Schneider; Stig Haunsø; Hans H Schiffer; Ethan S Burstein; David M Weiner; Søren P Sheikh
Journal:  Eur J Pharmacol       Date:  2008-05-20       Impact factor: 4.432

Review 4.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

5.  Chimeric muscarinic cholinergic: beta-adrenergic receptors that activate Gs in response to muscarinic agonists.

Authors:  S K Wong; E M Parker; E M Ross
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

6.  Selective coupling of alpha 2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells.

Authors:  D J Pepperl; J W Regan
Journal:  Mol Pharmacol       Date:  1993-10       Impact factor: 4.436

7.  Evidence for participation of calcineurin in potentiation of agonist-stimulated cyclic AMP formation by the calcium-mobilizing hormone, angiotensin II.

Authors:  A J Baukal; L Hunyady; K J Catt; T Balla
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

Review 8.  Therapeutic potential of β-arrestin- and G protein-biased agonists.

Authors:  Erin J Whalen; Sudarshan Rajagopal; Robert J Lefkowitz
Journal:  Trends Mol Med       Date:  2010-12-21       Impact factor: 11.951

9.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

10.  Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.

Authors:  Jihee Kim; Seungkirl Ahn; Keshava Rajagopal; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2009-03-02       Impact factor: 5.157

View more
  82 in total

1.  6'-Guanidinonaltrindole (6'-GNTI) is a G protein-biased κ-opioid receptor agonist that inhibits arrestin recruitment.

Authors:  Marie-Laure Rives; Mary Rossillo; Lee-Yuan Liu-Chen; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

2.  Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling.

Authors:  Céline M'Kadmi; Jean-Philippe Leyris; Lauriane Onfroy; Céline Galés; Aude Saulière; Didier Gagne; Marjorie Damian; Sophie Mary; Mathieu Maingot; Séverine Denoyelle; Pascal Verdié; Jean-Alain Fehrentz; Jean Martinez; Jean-Louis Banères; Jacky Marie
Journal:  J Biol Chem       Date:  2015-09-11       Impact factor: 5.157

3.  Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors.

Authors:  Ikuo Masuho; Olga Ostrovskaya; Grant M Kramer; Christopher D Jones; Keqiang Xie; Kirill A Martemyanov
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

5.  Saralasin and Sarile Are AT2 Receptor Agonists.

Authors:  Marie-Odile Guimond; Mathias Hallberg; Nicole Gallo-Payet; Charlotta Wallinder
Journal:  ACS Med Chem Lett       Date:  2014-08-18       Impact factor: 4.345

6.  Mutation of three residues in the third intracellular loop of the dopamine D2 receptor creates an internalization-defective receptor.

Authors:  Cecilea C Clayton; Prashant Donthamsetti; Nevin A Lambert; Jonathan A Javitch; Kim A Neve
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

7.  Biased signaling at chemokine receptors.

Authors:  Jenny Corbisier; Céline Galès; Alexandre Huszagh; Marc Parmentier; Jean-Yves Springael
Journal:  J Biol Chem       Date:  2015-01-22       Impact factor: 5.157

Review 8.  Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.

Authors:  Louis M Luttrell; Stuart Maudsley; Laura M Bohn
Journal:  Mol Pharmacol       Date:  2015-07-01       Impact factor: 4.436

9.  A multiplexed fluorescent assay for independent second-messenger systems: decoding GPCR activation in living cells.

Authors:  Paul H Tewson; Anne Marie Quinn; Thomas E Hughes
Journal:  J Biomol Screen       Date:  2013-04-11

10.  Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.

Authors:  Alynne Carvalho-Galvão; Blessing Ogunlade; Jiaxi Xu; Cristiane R A Silva-Alves; Leônidas G Mendes-Júnior; Drielle D Guimarães; Josiane C Cruz; Thyago M Queiroz; Camille M Balarini; Valdir A Braga; Catalin M Filipeanu; Eric Lazartigues; Maria do Socorro de França-Silva
Journal:  Clin Sci (Lond)       Date:  2018-07-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.